Tague, L. K., Byers, D. E., Hachem, R., Kreisel, D., Krupnick, A. S., Kulkarni, H. S., . . . Gelman, A. (2019). Impact of SLCO1B3 Polymorphisms on Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid. Pharmacogenomics J.
Chicago Style CitationTague, Laneshia K., Derek E. Byers, Ramsey Hachem, Daniel Kreisel, Alexander S. Krupnick, Hrishikesh S. Kulkarni, Catherine Chen, Howard J. Huang, i Andrew Gelman. "Impact of SLCO1B3 Polymorphisms On Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid." Pharmacogenomics J 2019.
Cita MLATague, Laneshia K., et al. "Impact of SLCO1B3 Polymorphisms On Clinical Outcomes in Lung Allograft Recipients Receiving Mycophenolic Acid." Pharmacogenomics J 2019.
Atenció: Aquestes cites poden no estar 100% correctes.